229 related articles for article (PubMed ID: 27784957)
1. Antiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphoma.
Merli M; Carli G; Arcaini L; Visco C
World J Gastroenterol; 2016 Oct; 22(38):8447-8458. PubMed ID: 27784957
[TBL] [Abstract][Full Text] [Related]
2. Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study.
Alric L; Besson C; Lapidus N; Jeannel J; Michot JM; Cacoub P; Canioni D; Pol S; Davi F; Rabiega P; Ysebaert L; Bonnet D; Hermine O
PLoS One; 2016; 11(10):e0162965. PubMed ID: 27749916
[TBL] [Abstract][Full Text] [Related]
3. Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.
Arcaini L; Merli M; Volpetti S; Rattotti S; Gotti M; Zaja F
Clin Dev Immunol; 2012; 2012():638185. PubMed ID: 22956970
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus-associated indolent B-cell lymphomas: A review on the role of the new direct antiviral agents therapy.
Mazzaro C; Dal Maso L; Visentini M; Ermacora A; Andreone P; Gattei V; Pozzato G
Hematol Oncol; 2021 Oct; 39(4):439-447. PubMed ID: 34477233
[TBL] [Abstract][Full Text] [Related]
5. HCV-associated B-cell non-Hodgkin lymphomas and new direct antiviral agents.
Carrier P; Jaccard A; Jacques J; Tabouret T; Debette-Gratien M; Abraham J; Mesturoux L; Marquet P; Alain S; Sautereau D; Essig M; Loustaud-Ratti V
Liver Int; 2015 Oct; 35(10):2222-7. PubMed ID: 26104059
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus-associated B-cell lymphomas: The importance of the new direct antiviral agent therapy.
Mazzaro C; Bomben R; Gragnani L; Visentini M; Pozzato G; Pozzo F; Zucchetto A; Gattei V
Semin Hematol; 2022 Oct; 59(4):177-182. PubMed ID: 36805885
[TBL] [Abstract][Full Text] [Related]
7. Antiviral therapies for managing viral hepatitis in lymphoma patients.
Merli M; Rattotti S; Gotti M; Arcaini L
Expert Opin Pharmacother; 2017 Mar; 18(4):363-376. PubMed ID: 28140702
[TBL] [Abstract][Full Text] [Related]
8. miRNA-26b downregulation in peripheral blood mononuclear cells of patients with hepatitis C associated lymphomas is restored by successful interferon-free antiviral therapy.
Peveling-Oberhag J; Bankov K; Dultz G; Ballo O; Lohmeyer J; Brunnberg U; Marcu V; Walter D; Zeuzem S; Hansmann ML; Welzel TM; Vermehren J
Antivir Ther; 2019; 24(6):437-442. PubMed ID: 31180334
[TBL] [Abstract][Full Text] [Related]
9. Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.
Arcaini L; Besson C; Frigeni M; Fontaine H; Goldaniga M; Casato M; Visentini M; Torres HA; Loustaud-Ratti V; Peveling-Oberhag J; Fabris P; Rossotti R; Zaja F; Rigacci L; Rattotti S; Bruno R; Merli M; Dorival C; Alric L; Jaccard A; Pol S; Carrat F; Ferretti VV; Visco C; Hermine O
Blood; 2016 Nov; 128(21):2527-2532. PubMed ID: 27605512
[TBL] [Abstract][Full Text] [Related]
10. Response to antiviral treatment in hepatitis C virus-associated marginal zone lymphomas.
Kelaidi C; Rollot F; Park S; Tulliez M; Christoforov B; Calmus Y; Podevin P; Bouscary D; Sogni P; Blanche P; Dreyfus F
Leukemia; 2004 Oct; 18(10):1711-6. PubMed ID: 15284859
[TBL] [Abstract][Full Text] [Related]
11. The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.
Peveling-Oberhag J; Arcaini L; Bankov K; Zeuzem S; Herrmann E
J Viral Hepat; 2016 Jul; 23(7):536-44. PubMed ID: 26924533
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection and antiviral treatment in marginal zone lymphomas.
Arcaini L; Bruno R
Curr Clin Pharmacol; 2010 May; 5(2):74-81. PubMed ID: 20156155
[TBL] [Abstract][Full Text] [Related]
13. From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?
Visentini M; Fiorilli M; Casato M
Expert Rev Hematol; 2017 Aug; 10(8):719-727. PubMed ID: 28675071
[TBL] [Abstract][Full Text] [Related]
14. HCV infection and non-Hodgkin lymphomas: an evolving story.
Defrancesco I; Zerbi C; Rattotti S; Merli M; Bruno R; Paulli M; Arcaini L
Clin Exp Med; 2020 Aug; 20(3):321-328. PubMed ID: 32052244
[TBL] [Abstract][Full Text] [Related]
15. Lymphomas associated with chronic hepatitis C virus infection: A prospective multicenter cohort study from the Rete Ematologica Lombarda (REL) clinical network.
Rattotti S; Ferretti VV; Rusconi C; Rossi A; Fogazzi S; Baldini L; Pioltelli P; Balzarotti M; Farina L; Ferreri AJM; Laszlo D; Speziale V; Varettoni M; Sciarra R; Morello L; Tedeschi A; Frigeni M; Defrancesco I; Zerbi C; Flospergher E; Nizzoli ME; Morra E; Arcaini L;
Hematol Oncol; 2019 Apr; 37(2):160-167. PubMed ID: 30726562
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C Virus and Interferon-Free Antiviral Therapeutics Revolution: Implications for Pakistan.
Afzal MS
Viral Immunol; 2017 May; 30(4):252-257. PubMed ID: 28118096
[TBL] [Abstract][Full Text] [Related]
17. Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.
Arcaini L; Vallisa D; Rattotti S; Ferretti VV; Ferreri AJM; Bernuzzi P; Merli M; Varettoni M; Chiappella A; Ambrosetti A; Tucci A; Rusconi C; Visco C; Spina M; Cabras G; Luminari S; Tucci M; Musto P; Ladetto M; Merli F; Stelitano C; d'Arco A; Rigacci L; Levis A; Rossi D; Spedini P; Mancuso S; Marino D; Bruno R; Baldini L; Pulsoni A
Ann Oncol; 2014 Jul; 25(7):1404-1410. PubMed ID: 24799461
[TBL] [Abstract][Full Text] [Related]
18. Role of anti-hepatitis C virus (HCV) treatment in HCV-related, low-grade, B-cell, non-Hodgkin's lymphoma: a multicenter Italian experience.
Vallisa D; Bernuzzi P; Arcaini L; Sacchi S; Callea V; Marasca R; Lazzaro A; Trabacchi E; Anselmi E; Arcari AL; Moroni C; Bertè R; Lazzarino M; Cavanna L
J Clin Oncol; 2005 Jan; 23(3):468-73. PubMed ID: 15659492
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis C virus-associated non-Hodgkin lymphomas: the endless history.
Pozzato G; Mazzaro C; Gattei V
Minerva Med; 2021 Apr; 112(2):215-227. PubMed ID: 33263375
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C-associated B-cell non-Hodgkin lymphomas. Epidemiology, molecular signature and clinical management.
Peveling-Oberhag J; Arcaini L; Hansmann ML; Zeuzem S
J Hepatol; 2013 Jul; 59(1):169-77. PubMed ID: 23542089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
